Alpha 2.0
Login Register
» Authors » Aykut Tahtali

Aykut Tahtali

Explore the profile of Aykut Tahtali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 62
Followers 0
Related Specialties
Oncology
Pharmacology
Radiology
Top 10 Co-Authors
Marc Diensthuber
Jens Wagenblast
Timo Stover
Martin Leinung
Christin Geissler
Reinhard Lissner
Shahram Ghanaati
Constanze Doring
Claus Rodel
Natalie Filman
Published In
Oncol Lett
Anticancer Res
Int J Clin Pharmacol Ther
Radiat Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Polyvalent immunoglobulins with vitamin D3 and vitamin B12 in the treatment of Sjogren's syndrome in a vegetarian with stomatitis, glossodynia, xerostomia, and elevated antinuclear antibodies: Case report

Cuny C, Vaerst B, Gabrielpillai J, Tahtali A, Balster S, Lissner R, et al.
Int J Clin Pharmacol Ther . 2017 Dec; 56(1):24-27. PMID: 29231165
Background: Sjogren's syndrome, involving sicca symptoms with xerostomia, stomatitis, and considerable pain is a difficult-to-treat autoimmune disease where the treatment options are limited and, as in the case of methotrexate,...
2.
Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges
Muller von der Grun J, Tahtali A, Ghanaati S, Rodel C, Balermpas P
Radiat Oncol . 2017 May; 12(1):82. PMID: 28486947
Background And Purpose: This review aims to provide a comprehensive overview of the literature and elucidate open questions for future clinical trials concerning diagnostics and treatment modalities for cervical cancer...
3.
Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification
Leinung M, Ernst B, Doring C, Wagenblast J, Tahtali A, Diensthuber M, et al.
Oncol Lett . 2015 Dec; 10(4):2289-2294. PMID: 26622836
In head and neck squamous cell carcinoma (HNSCC), aldehyde dehydrogenase 1 family, member A1 (ALDH1A1) and hyaluronan receptor cluster of differentiation 44 (CD44) are often used as cancer stem cell...
4.
HPV status and overall survival of patients with oropharyngeal squamous cell carcinoma--a retrospective study of a German head and neck cancer center
Tahtali A, Hey C, Geissler C, Filman N, Diensthuber M, Leinung M, et al.
Anticancer Res . 2013 Jul; 33(8):3481-5. PMID: 23898123
Background/aim: A change in epidemiology of head and neck squamous cell carcinoma (HNSCC) has been noticed: while overall incidence has decreased, the incidence of oropharyngeal SCC (OSCC) has been increasing...
5.
The role of p16 expression as a predictive marker in HPV-positive oral SCCHN--a retrospective single-center study
Geissler C, Tahtali A, Diensthuber M, Gassner D, Stover T, Wagenblast J
Anticancer Res . 2013 Mar; 33(3):913-6. PMID: 23482761
Unlabelled: Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common type of cancer worldwide; 600,000 new cases are diagnosed every year. Infected with high-risk human...
6.
Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHN
Leinung M, Hirth D, Tahtali A, Diensthuber M, Stover T, Wagenblast J
Oncol Lett . 2012 Dec; 4(6):1305-1308. PMID: 23226805
Inhibition of the proteasome with Bortezomib as well as inhibition of Polo-like-kinase-1 (PLK-1) has been shown to be effective in many solid tumour models and also in squamous cell carcinoma...